Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sandeep Laumas currently holds 17,000 shares of INNOVATE BIOPHARMACEUTICALS, INC. (INNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sandeep Laumas has been a net seller of INNT stock. They have purchased $38.9K and sold $701.7K worth of shares.
Sandeep Laumas's most recent insider trade was on Jan 9, 2026, when they sold 17,000 shares at $0.00 per share.
Sandeep Laumas serves as Executive at INNOVATE BIOPHARMACEUTICALS, INC. (INNT). They have executed 25 insider transactions totaling $740.6K over their tenure at the company.
Sandeep Laumas holds the position of Executive at INNOVATE BIOPHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Sandeep Laumas has shown a selling trading pattern, with $38.9K in total purchases and $701.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sandeep Laumas was on Sep 10, 2025, when they sold $404.1K worth of TIL shares. This transaction involved 17,539 shares at $23.04 per share.
Sandeep Laumas currently owns 17,000 shares of INNOVATE BIOPHARMACEUTICALS, INC. (INNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sandeep Laumas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sandeep Laumas has 25 Form 4 filings on record as an insider at INNOVATE BIOPHARMACEUTICALS, INC..
Set alerts for Sandeep Laumas and 40,000+ other insiders.